100% medical device-focused CRO
APS, now part of NAMSA, is a full-service CRO offering a full preclinical program including biocompatibility, analytical services, histopathology, interventional and surgical research. As part of NAMSA, clients are offered full-continuum development solutions ranging from medical device testing, regulatory, reimbursement and quality consulting, and clinical research services.